Ruxolitinib Treatment in Inclusion Body Myositis

NCT06536166 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Inclusion Body Myositis, Sporadic

Interventions

DRUG: Ruxolitinib
DRUG: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris